LENCI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 6.365
AS - Asia 793
EU - Europa 626
SA - Sud America 70
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 5
OC - Oceania 1
Totale 7.866
Nazione #
US - Stati Uniti d'America 6.355
SG - Singapore 429
IE - Irlanda 154
IT - Italia 130
CN - Cina 125
HK - Hong Kong 103
RU - Federazione Russa 84
DE - Germania 76
KR - Corea 75
BR - Brasile 63
GB - Regno Unito 56
UA - Ucraina 22
FI - Finlandia 18
SE - Svezia 16
AT - Austria 15
FR - Francia 14
BE - Belgio 12
ID - Indonesia 12
CZ - Repubblica Ceca 11
IN - India 10
CA - Canada 7
PK - Pakistan 6
NL - Olanda 5
VN - Vietnam 5
EU - Europa 4
QA - Qatar 4
TM - Turkmenistan 4
EG - Egitto 3
ES - Italia 3
IR - Iran 3
LT - Lituania 3
PL - Polonia 3
VE - Venezuela 3
AR - Argentina 2
JP - Giappone 2
TR - Turchia 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KW - Kuwait 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 7.866
Città #
Wilmington 1.912
Houston 1.569
Woodbridge 520
Fairfield 369
Singapore 341
Chandler 321
Ashburn 193
Dublin 134
Seattle 116
Cambridge 115
Medford 105
New York 100
Hong Kong 99
Ann Arbor 91
Santa Clara 73
Rome 60
Lawrence 48
Beijing 40
Council Bluffs 36
San Diego 30
Menlo Park 26
Munich 22
Seoul 22
Dearborn 21
Nuremberg 19
Palo Alto 18
Moscow 15
Creede 14
Engelhard 14
London 14
Helsinki 13
Brussels 12
Jakarta 12
Jacksonville 11
Los Angeles 11
Washington 11
Redwood City 10
Boardman 9
Colorado Springs 9
Shanghai 9
Vienna 9
Hangzhou 8
Hefei 8
Brno 7
Nanjing 7
Hounslow 6
Miami 6
São Paulo 6
Toronto 6
Lahore 5
Milan 5
St. George 5
Cagliari 4
Cassino 4
Doha 4
Dong Ket 4
Islington 4
Kilburn 4
La Veta 4
Norwalk 4
Shenzhen 4
Tianjin 4
Bloomfield 3
Curitiba 3
Guangzhou 3
Las Vegas 3
Mountain View 3
Nanchang 3
Olomouc 3
Zhengzhou 3
Caracas 2
Central 2
Chateaugiron 2
Chiswick 2
Clearwater 2
Esslingen am Neckar 2
Falls Church 2
Fremont 2
Guidonia Montecelio 2
Hanover 2
Istanbul 2
Jinan 2
Lappeenranta 2
Mislata 2
North Shields 2
Rio de Janeiro 2
Saint Petersburg 2
San Mateo 2
Shenyang 2
Southwark 2
Taipei 2
Tappahannock 2
Tashkent 2
The Dalles 2
Turin 2
Xi'an 2
Xuzhou 2
Adliswil 1
Alegrete 1
Alta Floresta 1
Totale 6.763
Nome #
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 448
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 380
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 372
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 305
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study 303
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 291
An unusual duodenal polyp causing anemia in a liver-transplanted patient 285
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 285
Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension 264
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 262
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 256
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 248
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 234
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 232
Dual role of bile acids on the biliary epithelium: Friend or foe? 200
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 190
Platelets and hepatocellular cancer: Bridging the bench to the clinics 170
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 164
Evaluation of liver fibrosis in cirrhotic patients: comparison between elastosonography and fibroscan 164
Liver transplantation for hepatocellular carcinoma: Where do we stand? 163
Domino liver transplantation: Where are we now? 157
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 151
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 148
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 146
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study 120
Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient 103
Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: differences and similarities along the path 100
Cholangiocarcinoma: Bridging the translational gap from preclinical to clinical development and implications for future therapy 96
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 89
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 81
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b 73
Natremia and liver transplantation: The right amount of salt for a good recipe 72
null 71
Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury 62
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 58
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 57
Molecular mechanisms linking risk factors to cholangiocarcinoma development 53
Gastrointestinal endoscopy in cirrhotic patient: Issues on the table 52
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment? 51
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 50
Chronic rejection after liver transplantation: Opening the Pandora's box 50
null 46
COVID-19 in normal, diseased and transplanted liver 46
The acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer in vivo, impairs HBsAg secretion and affects its structural stability in vitro 43
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage 43
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 43
null 42
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 41
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 40
Role of Cone-Beam CT in the Intraprocedural Evaluation of Chemoembolization of Hepatocellular Carcinoma 39
New strategies on management of hepatitis b virus after liver transplantation: complete and sustained weaning of hbv prophylaxis in a selected cohort of patients transplanted due to hbv-related cirrhosis 39
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 38
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 38
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 38
Secondary bile acids and the biliary epithelia: The good and the bad 36
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 35
Towards tolerance in liver transplantation 34
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 34
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 32
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 32
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 30
Use of intravascular ultrasound to improve diagnosis and treatment of transjugular intrahepatic portosystemic shunt dysfunction in patients in the long-term follow-up 30
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 29
Repeated TACE in HCC after Fontan surgery and situs viscerum inversus: A case report 28
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 27
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 27
The acquisition of positively charged amino acids in HBsAg C- terminus impairs HBsAg secretion, affects its structural stability and is associated with HBV-induced liver cancer 26
THE ENRICHMENT OF POSITIVELY CHARGED AMINO ACIDS IN HBsAg C-TERMINUS IMPAIRS HBsAg SECRETION, AFFECTS ITS STRUCTURAL STABILITY AND IS CORRELATED WITH HBV-INDUCED LIVER CANCER. 24
Development of Autoimmune Hepatitis after COVID-19 Infection in Vaccinated Women 22
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 22
null 22
Sequence of events leading to primary biliary cholangitis 20
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation 19
The Effects of Sustained Immunosuppression Withdrawal After Liver Transplantation on Metabolic Syndrome 18
Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study 18
Benign disease and unexpected histologocal findings after pancreaticoduodenectomy: The role of endoscopic ultrasound fine needle aspiration 16
Saline Contrast Echocardiography in Patients With Hepatopulmonary Syndrome Awaiting Liver Transplantation 15
Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study 13
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 10
Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication 7
Moving forward in the treatment of cholangiocarcinoma 6
Sarco-Model: a score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 6
Liver Transplantation For HDV/HBV Coinfection In Italy: An Intention-To-Treat Analysis Of Long-Term Outcomes 5
Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance 4
Totale 8.239
Categoria #
all - tutte 31.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020865 0 0 0 0 0 0 0 0 230 233 193 209
2020/20211.884 194 198 189 196 205 273 252 212 27 81 30 27
2021/2022606 28 62 18 27 9 72 46 24 71 60 38 151
2022/2023805 75 79 46 88 80 156 72 72 73 11 32 21
2023/2024490 60 16 43 13 65 138 12 15 14 54 4 56
2024/20251.286 57 353 206 107 30 194 171 74 94 0 0 0
Totale 8.239